Cargando…
Native Mass Spectrometry in Fragment-Based Drug Discovery
The advent of native mass spectrometry (MS) in 1990 led to the development of new mass spectrometry instrumentation and methodologies for the analysis of noncovalent protein–ligand complexes. Native MS has matured to become a fast, simple, highly sensitive and automatable technique with well-establi...
Autores principales: | Pedro, Liliana, Quinn, Ronald J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274484/ https://www.ncbi.nlm.nih.gov/pubmed/27483215 http://dx.doi.org/10.3390/molecules21080984 |
Ejemplares similares
-
Fragment-Based Screening of a Natural Product Library
against 62 Potential Malaria Drug Targets Employing Native Mass Spectrometry
por: Vu, Hoan, et al.
Publicado: (2018) -
High-Throughput Native Mass Spectrometry Screening in Drug Discovery
por: Gavriilidou, Agni F. M., et al.
Publicado: (2022) -
Fragment-based screening with natural products for novel anti-parasitic disease drug discovery
por: Liu, Miaomiao, et al.
Publicado: (2019) -
Development of a target identification approach using native mass spectrometry
por: Liu, Miaomiao, et al.
Publicado: (2021) -
MolDiscovery: learning mass spectrometry fragmentation of small molecules
por: Cao, Liu, et al.
Publicado: (2021)